PharmaCielo Ltd. (PCLOF) Financials
PCLOF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 9.0 million | 16.9 million |
| Dec. 31, 2025 | 6.2 million | 17.4 million |
| Sept. 30, 2025 | 6.2 million | 16.9 million |
| June 30, 2025 | 13.3 million | 21.4 million |
PCLOF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -2.7 million | ? |
| Dec. 31, 2025 | 386814 | 19782 |
| Sept. 30, 2025 | -2.5 million | 19478 |
| June 30, 2025 | 1.6 million | ? |
PCLOF Net Income
No data available :(
PCLOF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 12593 | - | - |
| Dec. 31, 2025 | 210801 | - | - |
| Sept. 30, 2025 | 184261 | - | - |
| June 30, 2025 | 4810 | - | - |
PCLOF Shares Outstanding
PCLOF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | - | 490764 | - |
| Dec. 31, 2025 | 3 | - | 234326 | 323 |
| Sept. 30, 2025 | 2 | - | 1.5 million | 3152 |
| June 30, 2025 | - | - | 611457 | - |
PCLOF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 516592 | 435957 |
| Dec. 31, 2025 | 441764 | -287217 |
| Sept. 30, 2025 | 638479 | 995200 |
| June 30, 2025 | 237221 | 227810 |
PCLOF
Price: $0.04
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 7.9 million